Oragenics, Inc.

1990 Main StreetSuite 750

Sarasota, Florida 34236

 

February 4, 2025

 

VIA EDGAR

 

United States Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

100 F Street, N.E.

Washington, D.C. 20549-3628

 

  Re: Oragenics, Inc. (the “Company”)
    Request to Withdraw Registration Statement on Form S-1
    Filed on December 18, 2024
    File No. 333-283927

 

Ladies and Gentlemen:

 

Pursuant to Rule 477 under the Securities Act of 1933, as amended (the “Securities Act”), Oragenics, Inc. (the “Registrant”) hereby respectfully requests that the Securities and Exchange Commission (the “Commission”) consent to the withdrawal, effective as of the date hereof or at the earliest practicable date hereafter, of the Registrant’s Registration Statement on Form S-1 (File No. 333-283927) filed with the Commission on December 18, 2024, together with all amendments and exhibits thereto (collectively, the “Registration Statement”), effective as of the date hereof.

 

The Registrant has decided not to pursue the offering due to business decisions and confirms that no securities covered by the Registration Statement have been issued or sold. Based on the foregoing, the Registrant submits that the withdrawal of the Registration Statement is consistent with the public interest and the protection of investors.

 

Pursuant to Rule 477(b) under the Securities Act, the Registrant understands that this request for withdrawal of the Registration Statement will be deemed granted as of the date hereof, unless the Registrant receives notice from the Commission within 15 days of the date hereof that such request will not be granted. In accordance with Rule 457(p) under the Securities Act, the Registrant requests that all fees paid to the Commission in connection with the filing of the Registration Statement be credited to the Registrant’s account for future use.

 

We appreciate your time and attention to this matter. Should you have any questions, please call our counsel, Julio Esquivel, of Shumaker, Loop & Kendrick, LLP, at (813) 227-2325.

 

  Very truly yours,
     
  By: /s/Janet Huffman
 

Name:

Janet Huffman
  Title: Chief Financial Officer

c: Julio C. Esquivel, Shumaker, Loop & Kendrick, LLP

 

 

 


Oragenics (AMEX:OGEN)
Historical Stock Chart
From Jan 2025 to Feb 2025 Click Here for more Oragenics Charts.
Oragenics (AMEX:OGEN)
Historical Stock Chart
From Feb 2024 to Feb 2025 Click Here for more Oragenics Charts.